Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1990 Oct;47(4):735–739.

Definitive prenatal diagnosis for type III glycogen storage disease.

B Z Yang 1, J H Ding 1, B I Brown 1, Y T Chen 1
PMCID: PMC1683804  PMID: 2220811

Abstract

Prenatal diagnosis for type III glycogen storage disease was performed by using (1) immunoblot analysis with a polyclonal antibody prepared against purified porcine-muscle debranching enzyme and (2) a qualitative assay for debranching-enzyme activity. Cultured amniotic fluid cells from three pregnancies (three families in which the proband had absence of debrancher protein) were subjected to immunoblot analysis. Two unaffected and one affected fetus were predicted. In addition, cultured amniotic fluid cells from nine pregnancies (eight families) were screened with a qualitative assay based on the persistence of a polysaccharide that has a structure approaching that of a phosphorylase limit dextrin when the cells were exposed to a glucose-free medium. This qualitative assay predicted six unaffected and three affected fetuses. All predictions by either method were confirmed postnatally except for one spontaneously aborted fetus. Our data indicate that a definitive diagnosis of type III glycogen storage disease can be made prenatally by these methods.

Full text

PDF
735

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chen Y. T., He J. K., Ding J. H., Brown B. I. Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease. Am J Hum Genet. 1987 Dec;41(6):1002–1015. [PMC free article] [PubMed] [Google Scholar]
  2. Ding J. H., de Barsy T., Brown B. I., Coleman R. A., Chen Y. T. Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III. J Pediatr. 1990 Jan;116(1):95–100. doi: 10.1016/s0022-3476(05)81652-x. [DOI] [PubMed] [Google Scholar]
  3. Fellows I. W., Lowe J. S., Ogilvie A. L., Stevens A., Toghill P. J., Atkinson M. Type III glycogenosis presenting as liver disease in adults with atypical histological features. J Clin Pathol. 1983 Apr;36(4):431–434. doi: 10.1136/jcp.36.4.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gutman A., Barash V., Schramm H., Deckelbaum R. J., Granot E., Aker M., Kohn G. Incorporation of [14C]glucose into alpha-1,4 bonds of glycogen by leukocytes and fibroblasts of patients with type III glycogen storage disease. Pediatr Res. 1985 Jan;19(1):28–32. doi: 10.1203/00006450-198501000-00009. [DOI] [PubMed] [Google Scholar]
  5. Maire I., Mandon G., Mathieu M. First trimester prenatal diagnosis of glycogen storage disease type III. J Inherit Metab Dis. 1989;12 (Suppl 2):292–294. doi: 10.1007/BF03335402. [DOI] [PubMed] [Google Scholar]
  6. Miller C. G., Alleyne G. A., Brooks S. E. Gross cardiac involvement in glycogen storage disease type 3. Br Heart J. 1972 Aug;34(8):862–864. doi: 10.1136/hrt.34.8.862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Moses S. W., Gadoth N., Bashan N., Ben-David E., Slonim A., Wanderman K. L. Neuromuscular involvement in glycogen storage disease type III. Acta Paediatr Scand. 1986 Mar;75(2):289–296. doi: 10.1111/j.1651-2227.1986.tb10201.x. [DOI] [PubMed] [Google Scholar]
  8. Olson L. J., Reeder G. S., Noller K. L., Edwards W. D., Howell R. R., Michels V. V. Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy. Am J Cardiol. 1984 Mar 15;53(7):980–981. doi: 10.1016/0002-9149(84)90551-4. [DOI] [PubMed] [Google Scholar]
  9. Shin Y. S., Rieth M., Tausenfreund J., Endres W. First trimester diagnosis of glycogen storage disease type II and type III. J Inherit Metab Dis. 1989;12 (Suppl 2):289–291. doi: 10.1007/BF03335401. [DOI] [PubMed] [Google Scholar]
  10. Starzl T. E., Putnam C. W., Porter K. A., Halgrimson C. G., Corman J., Brown B. I., Gotlin R. W., Rodgerson D. O., Greene H. L. Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg. 1973 Oct;178(4):525–539. doi: 10.1097/00000658-197310000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. van Diggelen O. P., Janse H. C., Smit G. P. Debranching enzyme in fibroblasts, amniotic fluid cells and chorionic villi: pre- and postnatal diagnosis of glycogenosis type III. Clin Chim Acta. 1985 Jul 15;149(2-3):129–134. doi: 10.1016/0009-8981(85)90326-2. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES